Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New p38 MAP kinase inhibitors identified by GSK researchers

Oct. 19, 2004

New peptide with vasodilatory activity isolated from frog skin secretion

Oct. 19, 2004

Theravance researchers claim dual beta2-AR agonists/muscarinic antagonists

Oct. 19, 2004

Novel 5-HT6 receptor ligands in early development at Wyeth

Oct. 19, 2004

New GLP-1 analogues and their use covered by SCRAS patent

Oct. 19, 2004

Novel polo-like kinase inhibitors developed at GSK

Oct. 19, 2004

Ranbaxy scientists describe new iminosugar-based anticancer agents

Oct. 19, 2004

New indole-containing oxazolidinone antibacterial agents identified at Pfizer

Oct. 18, 2004

New benzofurans acting as 5-HT reuptake inhibitors and 5-HT receptor ligands

Oct. 18, 2004

Neurogen presents novel GABA-A receptor modulators

Oct. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...